Free Trial

Apyx Medical (APYX) Short Interest Ratio & Short Volume

Apyx Medical logo
$1.19 -0.13 (-9.85%)
Closing price 04:00 PM Eastern
Extended Trading
$1.24 +0.05 (+4.20%)
As of 05:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Apyx Medical Short Interest Data

Apyx Medical (APYX) has a short interest of 141,900 shares, representing 0.44% of the float (the number of shares available for trading by the public). This marks a -4.89% decrease in short interest from the previous month. The short interest ratio (days to cover) is 3.2, indicating that it would take 3.2 days of the average trading volume of 67,504 shares to cover all short positions.

Current Short Interest
141,900 shares
Previous Short Interest
149,200 shares
Change Vs. Previous Month
-4.89%
Dollar Volume Sold Short
$212,850.00
Short Interest Ratio
3.2 Days to Cover
Last Record Date
February 15, 2025
Outstanding Shares
37,644,000 shares
Float Size
32,040,000 shares
Short Percent of Float
0.44%
Today's Trading Volume
39,873 shares
Average Trading Volume
67,504 shares
Today's Volume Vs. Average
59%
Short Selling Apyx Medical?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Apyx Medical and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

APYX Short Interest Over Time

APYX Days to Cover Over Time

APYX Percentage of Float Shorted Over Time

Apyx Medical Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
2/15/2025141,900 shares $212,850.00 -4.9%0.4%3.2 $1.50
1/31/2025149,200 shares $214,848.00 +0.4%0.5%2.7 $1.44
1/15/2025148,600 shares $211,012.00 +17.6%0.5%2.5 $1.42
12/31/2024126,400 shares $199,712.00 +1.8%0.4%2.2 $1.58
12/15/2024124,200 shares $208,656.00 +3.5%0.4%2.3 $1.68
11/30/2024120,000 shares $193,200.00 -14.6%0.4%2.3 $1.61
11/15/2024140,500 shares $177,030.00 -39.0%0.5%3.3 $1.26
10/31/2024230,300 shares $269,451.00 -2.0%0.8%5.7 $1.17
10/15/2024234,900 shares $277,182.00 -0.5%0.8%6.4 $1.18
9/30/2024236,100 shares $292,764.00 -3.2%0.8%6.4 $1.24
9/15/2024243,900 shares $282,924.00 -8.0%0.8%6.9 $1.16
8/31/2024265,100 shares $352,583.00 -10.7%0.9%7.6 $1.33
8/15/2024296,900 shares $409,722.00 +4.0%1.0%7.8 $1.38
7/31/2024285,600 shares $388,416.00 +1.8%1.0%5.3 $1.36
7/15/2024280,600 shares $384,422.00 -3.7%1.0%5.2 $1.37
6/30/2024291,500 shares $390,610.00 -2.5%1.0%4.9 $1.34
6/15/2024298,900 shares $433,405.00 -8.7%1.1%2.5 $1.45
5/31/2024327,500 shares $540,375.00 -20.6%1.2%2.3 $1.65
5/15/2024412,600 shares $581,766.00 -23.6%1.5%2.8 $1.41
4/30/2024540,300 shares $772,629.00 +45.6%1.9%3.7 $1.43
4/15/2024371,100 shares $512,118.00 -47.5%1.3%2.4 $1.38
3/31/2024706,700 shares $961,112.00 -55.0%2.5%4.4 $1.36
3/15/20241,570,000 shares $2.81 million -1.3%5.2%10.1 $1.79
2/29/20241,590,000 shares $3.34 million +1.3%5.3%15.8 $2.10
2/15/20241,570,000 shares $3.36 million +4.0%5.2%14 $2.14
1/31/20241,510,000 shares $3.38 million -3.2%5.0%10.6 $2.24
1/15/20241,560,000 shares $3.46 million -1.9%5.2%10.8 $2.22
12/31/20231,590,000 shares $4.17 million -1.9%5.3%10 $2.62
12/15/20231,620,000 shares $3.81 million +1.3%5.4%9.9 $2.35
11/30/20231,600,000 shares $3.78 million -20.8%5.3%9.9 $2.36
11/15/20232,020,000 shares $3.01 million -9.0%6.7%13.7 $1.49
10/31/20232,220,000 shares $5.08 million -7.1%7.4%14.3 $2.29
10/15/20232,390,000 shares $5.63 million -8.1%7.9%12.3 $2.36
9/30/20232,600,000 shares $8.32 million -3.4%8.6%13 $3.20
9/15/20232,690,000 shares $10.52 million -5.6%8.9%10.8 $3.91
8/31/20232,850,000 shares $13.28 million -16.7%9.4%10.6 $4.66
8/15/20233,420,000 shares $16.25 million +39.6%11.3%12 $4.75
7/31/20232,450,000 shares $13.70 million -13.4%8.1%7 $5.59
7/15/20232,830,000 shares $17.09 million +9.7%9.4%9 $6.04
6/30/20232,580,000 shares $12.98 million -27.9%8.5%8.9 $5.03
Elon’s “New Gold” (Ad)

MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest breakthrough in artificial intelligence… but in human technology. It’s so valuable that some are referring to it as the “new gold”.

I reveal all of the details here.
6/15/20233,580,000 shares $24.88 million -3.5%11.9%14.9 $6.95
5/31/20233,710,000 shares $23.48 million -35.1%12.3%16.7 $6.33
5/15/20235,720,000 shares $32.03 million +17.5%18.9%23.5 $5.60
4/30/20234,870,000 shares $16.56 million +3.4%16.1%34.7 $3.40
4/15/20234,710,000 shares $14.13 million +12.7%15.6%27.7 $3.00
3/31/20234,180,000 shares $12.04 million +1.7%13.8%21.2 $2.88
3/15/20234,110,000 shares $10.77 million +25.7%13.6%19.2 $2.62
2/28/20233,270,000 shares $10.63 million +2.5%10.8%14.7 $3.25
2/15/20233,190,000 shares $10.53 million +4.6%10.6%13.2 $3.30
1/31/20233,050,000 shares $8.91 million +146.0%10.1%8 $2.92
1/15/20231,240,000 shares $3.21 million +42.5%4.1%3.5 $2.59
12/30/2022870,400 shares $2.04 million -5.0%2.9%2.7 $2.34
12/15/2022916,400 shares $1.76 million -3.0%3.0%3 $1.92
11/30/2022944,700 shares $1.66 million -21.9%3.1%3.2 $1.76
11/15/20221,210,000 shares $2.11 million +42.6%4.0%4.1 $1.74
10/31/2022848,800 shares $4.24 million +10.4%2.8%6.5 $5.00
10/15/2022768,600 shares $3.15 million +8.2%2.6%6 $4.10
9/30/2022710,600 shares $3.19 million +49.8%2.4%5 $4.49
9/15/2022474,300 shares $2.91 million -3.1%1.6%2.1 $6.14
8/31/2022489,200 shares $2.80 million -19.3%1.6%1.9 $5.73
8/15/2022606,100 shares $4.53 million -28.1%2.0%0.8 $7.47
7/31/2022842,500 shares $7.97 million +25.3%2.8%1.1 $9.46
7/15/2022672,600 shares $5.04 million -13.2%2.2%0.9 $7.50
6/30/2022775,000 shares $4.54 million -58.8%2.7%1 $5.86
6/15/20221,880,000 shares $11.37 million -33.1%6.5%2.5 $6.05
5/31/20222,810,000 shares $17.06 million +138.1%9.3%4.1 $6.07
5/15/20221,180,000 shares $4.31 million +21.8%3.9%7.9 $3.65
4/30/2022968,500 shares $3.65 million +25.6%3.2%7.4 $3.77
4/15/2022771,100 shares $4.13 million +40.6%2.6%6.9 $5.35
3/31/2022548,600 shares $3.58 million +12.4%1.8%5.4 $6.53
3/15/2022488,300 shares $2.87 million +11.1%1.6%5.6 $5.87
2/28/2022439,500 shares $4.45 million +7.9%1.5%7.8 $10.12
2/15/2022407,300 shares $4.29 million +18.0%1.4%6.3 $10.53
1/31/2022345,200 shares $3.97 million -10.6%1.2%4.6 $11.50
1/15/2022386,000 shares $4.49 million +11.7%1.3%5.1 $11.63
12/31/2021345,600 shares $4.43 million -2.4%1.2%4.8 $12.82
12/15/2021354,100 shares $4.49 million -5.9%1.2%3.5 $12.69
11/30/2021376,100 shares $5.05 million -7.6%1.3%3.8 $13.43
11/15/2021407,000 shares $6.63 million -14.3%1.4%4.2 $16.30
10/29/2021475,000 shares $6.79 million -5.9%1.6%5.3 $14.30
10/15/2021504,500 shares $6.63 million -6.9%1.7%5.9 $13.15
9/30/2021542,100 shares $7.51 million +10.0%1.8%6.4 $13.85
9/15/2021492,800 shares $5.48 million +2.9%1.6%6.5 $11.11
8/31/2021478,900 shares $5.66 million +5.0%1.6%6.1 $11.81
8/13/2021456,300 shares $4.98 million +0.9%1.5%5.8 $10.91
7/30/2021452,100 shares $4.07 million -0.8%1.5%5.7 $9.00
7/15/2021455,900 shares $4.17 million -0.6%1.5%5.5 $9.14
6/30/2021458,500 shares $4.73 million -15.7%1.5%5 $10.31
6/15/2021544,100 shares $5.52 million -4.6%1.8%7.2 $10.15
5/28/2021570,400 shares $5.58 million +2.6%1.9%7.3 $9.79
Elon’s “New Gold” (Ad)

MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest breakthrough in artificial intelligence… but in human technology. It’s so valuable that some are referring to it as the “new gold”.

I reveal all of the details here.
5/14/2021555,800 shares $5.39 million +9.2%1.9%6.4 $9.70
4/30/2021508,900 shares $5.16 million -5.3%1.7%6.1 $10.14
4/15/2021537,200 shares $5.07 million -7.7%1.8%5.9 $9.44
3/31/2021581,800 shares $5.75 million -6.1%1.9%6.1 $9.88
3/15/2021619,300 shares $7.12 million -0.7%2.1%7 $11.49
2/26/2021623,700 shares $6.56 million +10.3%2.1%7.4 $10.51
2/12/2021565,500 shares $5.79 million +4.3%1.9%6.7 $10.24
1/29/2021542,000 shares $5.13 million +4.3%1.8%6.5 $9.47
1/15/2021519,900 shares $4.81 million -1.4%1.7%6.6 $9.26
12/31/2020527,000 shares $3.94 million +1.9%1.8%8.9 $7.48
12/15/2020517,200 shares $3.59 million +0.5%1.7%9.1 $6.94
11/30/2020514,700 shares $3.98 million +0.9%1.7%9.2 $7.73
11/15/2020510,100 shares $3.42 million -0.4%1.7%8.9 $6.71
10/30/2020512,100 shares $3.00 million -3.9%1.7%8.9 $5.86
10/15/2020532,700 shares $2.95 million +1.2%1.8%8.5 $5.53
9/30/2020526,600 shares $2.48 million +2.4%1.8%7.9 $4.71
9/15/2020514,100 shares $2.58 million -0.2%1.7%6.1 $5.01
8/31/2020515,300 shares $2.37 million -13.9%1.7%4.6 $4.59
8/14/2020598,600 shares $3.03 million -10.4%2.0%5.1 $5.07
7/31/2020668,000 shares $3.00 million +10.7%2.2%5.1 $4.49
7/15/2020603,700 shares $2.97 million +6.4%2.0%4.6 $4.92
6/30/2020567,300 shares $3.15 million +43.6%1.9%4.2 $5.55
6/15/2020395,200 shares $1.92 million -11.0%1.3%3 $4.87
5/29/2020443,800 shares $1.97 million +24.2%1.5%3.7 $4.44
5/15/2020357,400 shares $1.29 million -3.1%1.2%3 $3.61
4/30/2020368,900 shares $1.38 million -22.7%1.3%3.6 $3.73
4/15/2020477,400 shares $1.67 million -9.5%1.6%5.1 $3.49
3/31/2020527,200 shares $1.78 million -44.9%1.8%5.6 $3.37
3/13/2020957,200 shares $3.80 million -5.2%3.2%11.1 $3.97

APYX Short Interest - Frequently Asked Questions

What is Apyx Medical's current short interest?

Short interest is the volume of Apyx Medical shares that have been sold short but have not yet been closed out or covered. As of February 15th, traders have sold 141,900 shares of APYX short. 0.44% of Apyx Medical's shares are currently sold short. Learn More on Apyx Medical's current short interest.

What is a good short interest ratio for Apyx Medical?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. APYX shares currently have a short interest ratio of 3.0. Learn More on Apyx Medical's short interest ratio.

Which institutional investors are shorting Apyx Medical?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Apyx Medical: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Apyx Medical?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.44% of Apyx Medical's floating shares are currently sold short.

Is Apyx Medical's short interest increasing or decreasing?

Apyx Medical saw a decline in short interest during the month of February. As of February 15th, there was short interest totaling 141,900 shares, a decline of 4.9% from the previous total of 149,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Apyx Medical's float size?

Apyx Medical currently has issued a total of 37,644,000 shares. Some of Apyx Medical's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Apyx Medical currently has a public float of 32,040,000 shares.

How does Apyx Medical's short interest compare to its competitors?

0.44% of Apyx Medical's shares are currently sold short. Here is how the short interest of companies in the industry of "medical equipment" compare to Apyx Medical: Inogen, Inc. (3.20%), BrainsWay Ltd. (0.53%), TriSalus Life Sciences, Inc. (1.19%), The Beauty Health Company (11.16%), LENSAR, Inc. (0.70%), Orchestra BioMed Holdings, Inc. (1.81%), KORU Medical Systems, Inc. (0.88%), Neuronetics, Inc. (5.84%), Sight Sciences, Inc. (4.74%), Pro-Dex, Inc. (1.04%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($25.81 billion), iShares 20+ Year Treasury Bond ETF ($10.38 billion), MicroStrategy Incorporated ($7.74 billion), AppLovin Co. ($6.32 billion), Apollo Global Management, Inc. ($5.97 billion), Super Micro Computer, Inc. ($4.89 billion), Charter Communications, Inc. ($4.52 billion), Capital One Financial Co. ($3.94 billion), Schlumberger Limited ($3.19 billion), and Reddit, Inc. ($3.01 billion). View all of the most shorted stocks.

What does it mean to sell short Apyx Medical stock?

Short selling APYX is an investing strategy that aims to generate trading profit from Apyx Medical as its price is falling. APYX shares are trading down $0.13 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Apyx Medical?

A short squeeze for Apyx Medical occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of APYX, which in turn drives the price of the stock up even further.

How often is Apyx Medical's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including APYX, twice per month. The most recent reporting period available is February, 15 2025.




This page (NASDAQ:APYX) was last updated on 3/4/2025 by MarketBeat.com Staff
From Our Partners